Innovative |潛在的COVID-19治療和細胞因子的作用

Innovative |潛在的COVID-19治療和細胞因子的作用


Potential COVID-19 Treatment and Cytokines Role

to support ongoing COVID-19 research

Cytokines include a group of proteins that are secreted primarily by the immune cell to help restrict COIVD-19. Some cytokines however, can also trigger inflammation which can be problematic.

A recent study has shown two cytokines in particular produce inflammatory cell death, which in turn causes the release of more cytokines and the issue causing inflammation; these two cytokines are Tumor Necrosis Factor (TNF)-Alpha and Interferon (IFN)-Gamma.

The finding was these cytokines paired together mirror the symptoms that one would see as a COVID-19 patient.

The study describes neutralizing antibodies against Tumor Necrosis Factor (TNF)-Alpha and Interferon (IFN)-Gamma were able to protect mice from death associated with SARS-CoV-2 infection. To learn more about this exciting discovery, please refer to the link down below.

We are excited about these advancements in the fight against COVID and offer a wide range of products related to this research and more.

Related Products

Supporting COVID-19 & Life Science Research

In case you missed it, we recently released our SARS-CoV-2 IgG Seroconversion ELISA Kit for the qualitative determination of SARS-CoV-2 specific antibodies of IgG class in plasma or serum samples. This kit is specific to the RBD of the spike protein, ensuring high sensitivity and specificity. We also offer a recombinant version of the SARS-CoV-2 Spike Protein RBD.

We also introduced our new Viral Transport Media (VTM) line and Synthetic Human Cerebrospinal Fluid (CSF) to help support ongoing research into COVID-19 and other life science applications.

We have recently seen increasing popularity among several of our products, and these continue to be available:


LINE 線上諮詢



error: Content is protected !!